Gengin M T, Vernigora A N, Nikishin N N, Makeeva N V
Vopr Med Khim. 1995 Sep-Oct;41(5):37-9.
Chronic consumption of the highly specific angiotension-converting enzyme inhibitor captopril was found to decrease the activity of the enzyme in the rat hypothalamus and striatum and to enhance it in the pituitary and blood serum. The agent also increased the activity of carboxypeptidase N in the serum and that of carboxypeptidase H in the pituitary. Reserpine, a catecholaminergic blocking agent, reduces the pituitary and serum activities of angiotensin-converting enzyme and activates soluble carboxypeptidase H in the pituitary and striatum and membrane-bound carboxypeptidase in the hypothalamus and striatum. Possible mechanisms of action of captopril and reserpine on the activity of the enzymes in question, as well as a contribution of these enzymes to their antihypertensive effect are discussed in the paper.
研究发现,长期服用高度特异性的血管紧张素转换酶抑制剂卡托普利可降低大鼠下丘脑和纹状体中该酶的活性,而垂体和血清中的活性则增强。该药物还增加了血清中羧肽酶N的活性以及垂体中羧肽酶H的活性。利血平是一种儿茶酚胺能阻断剂,可降低垂体和血清中血管紧张素转换酶的活性,并激活垂体和纹状体中的可溶性羧肽酶H以及下丘脑和纹状体中的膜结合羧肽酶。本文讨论了卡托普利和利血平对相关酶活性的可能作用机制,以及这些酶对其降压作用的贡献。